argenx Management Team to Speak at Major Investor Events

Author: Dylan Bailey Updated: 08-28-2025 01:16 AM

Upcoming Investor Conferences for argenx Management

Argentx (Euronext & Nasdaq: ARGX), a leading global player in immunology, is gearing up to participate in key investor conferences. With a mission to enhance the lives of individuals suffering from severe autoimmune diseases, the management team aims to showcase their commitment and advancements in this critical area.

Details of the Conferences

In September, argenx will be represented at several significant conferences:

Wells Fargo Healthcare Conference

A fireside chat is scheduled for Thursday, September 4, offering insights into the company’s initiatives and goals at 8:00 a.m. ET in Boston.

Morgan Stanley Global Healthcare Conference

Following the Wells Fargo event, on Monday, September 8, the management will be in New York for another engaging fireside chat at 7:00 a.m. ET. These events are excellent opportunities for investors to gain direct insights from the leaders of argenx.

Accessing the Presentations

Investors and interested parties can catch a live webcast of these presentations via the Investors section of the argenx website. Each presentation will be available for replay for approximately 30 days following the event, ensuring that everyone has the chance to stay informed about argenx’s progress.

About argenx

Argentx operates with a clear focus on immunology, developing innovative solutions that help those impacted by autoimmune diseases. The company is a pioneer in the field, having launched the first approved neonatal Fc receptor (FcRn) blocker. This groundbreaking achievement is just one of many steps in their quest to explore the full potential of antibody-based medications.

Through partnerships with esteemed academic institutions under their Immunology Innovation Program (IIP), argenx is working to transition research breakthroughs into actionable and effective treatments. Their efforts in advancing biological therapies are not just beneficial but transformative for those living with serious health challenges.

For more information about argenx and their ongoing endeavors, please visit their official website or follow them on social media channels, including LinkedIn, Instagram, Facebook, and YouTube.

Point of Contact

For media inquiries, please reach out to Ben Petok, who is available at bpetok@argenx.com. Investors can connect with Alexandra Roy through aroy@argenx.com for any investment-related questions.

Frequently Asked Questions

What is argenx?

Argentx is a global immunology company dedicated to improving the lives of individuals suffering from severe autoimmune diseases.

What conferences is argenx attending?

Argentx will be participating in the Wells Fargo Healthcare Conference and the Morgan Stanley Global Healthcare Conference in September.

How can I access the conference presentations?

The presentations will be available live on argenx's website and can be replayed for approximately 30 days after the events.

What is argenx’s focus in the medical field?

Argentx focuses on developing innovative antibody-based therapies to address unmet needs in severe autoimmune diseases.

Who can I contact for more information?

You can reach Ben Petok for media inquiries and Alexandra Roy for investor relations via their provided email addresses.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.